
Daily Target 2X Long MRNA ETF
$162.11−1.48 (−0.90%)
- 1.34%
- $31M
- 265K sh
- low $14.95high $227.90
The ETF.net MRNX Grade
Score 48 out of 100
- 94 of 380
Score 48 of 100 falls in the C band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.
Cost
The fund’s net expense ratio, ranked against its category.F22 out of 100Rank 296 of 380Mission
Whether the fund did what it promised, tested against its stated mandate.A90 out of 100Rank 77 of 150Risk
How the fund held up when markets fell: downside volatility, drawdowns and tail loss.A72 out of 100Rank 67 of 368Tradability
How easy the fund is to trade: daily volume, and how far its price strays from net asset value.A74 out of 100Rank 68 of 380Holdings
How concentrated the fund is, and how complete and current its disclosed holdings are.Durability
Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.B65 out of 100Rank 88 of 380
Our read on MRNX
In short
CMost 2x single-stock ETFs point at megacap tech. MRNX aims the same machinery at Moderna, a biotech that moves on trial data and FDA headlines, targeting two times MRNA's daily move. Built as a short-term trading tool, priced at 1.34%.
Stated mandate
The Fund seeks daily leveraged results equal to two times the daily percentage change in Moderna, Inc.'s share price, before fees and expenses.
Why people hold it
Worth knowing
MRNX Holdings
- Other
- 9
- 267%
- United States Treasury Bill 11/19/2026
Geography
- United States100.00%
MRNX Performance
Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.
Returns run to the Oct 30, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.
| Period | MRNX |
|---|---|
| Year to date | |
| 1 month | +16.0% |
| 3 months | +574.0% |
| 1 year | |
| 3 years | |
| 5 years | |
| 10 years |
Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.
| Year | Return bar | MRNX |
|---|---|---|
| 2026 YTD | +702.7% |
MRNX in the news
MRNX Dividends
Listed Feb 2026. No distributions yet.
MRNX Risk
This fund targets a multiple of the daily move of its index and resets daily. Hold it longer than one reset and compounding makes the return diverge from that target. In choppy markets it can lose value even when the index ends flat.
How it’s calculated: standard deviation
The sample standard deviation of monthly total returns, multiplied by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.
How it’s calculated: Sharpe ratio
Subtract each month’s Treasury-bill return from the fund’s monthly total return.
Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.
How it’s calculated: maximum drawdown
The largest percentage decline from an earlier peak, using total returns with reinvested distributions.
Uses up to five years through the last close, with at least 12 months required.
- −1.97
How it’s calculated: beta
The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.
FMP measures it over up to five years of monthly returns.
MRNX Cost
Overpaying vs GOGL, tied cheapest in Single-Stock Long Leveraged
$19,810
On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.
MRNX 1.34%
$23,965
GOGL 0.20% Tied cheapest
$4,155
Cost over time
Year by year
| Year | MRNX | GOGL | Overpaying |
|---|---|---|---|
| 10 | $2,329 | $365 | $1,964 |
| 20 | $8,621 | $1,421 | $7,200 |
| 30 | $23,965 | $4,155 | $19,810 |
Other funds in Single-Stock Long Leveraged
- CSMCXDaily Target 2X Long SMCI ETFExpense ratio 1.32%1 year return −57.8%
- CLLYXDaily Target 2X Long LLY ETFExpense ratio 1.49%1 year return +110.2%
- CTSMUGraniteShares 2x Long TSM Daily ETFExpense ratio 1.50%1 year return +34.9%
- CAEHGLeverage Shares 2X Long AEHR Daily ETFExpense ratio 0.99%1 year return
- CNVOXDefiance Daily Target 2X Long NVO ETFExpense ratio 1.31%1 year return −53.1%




